tiprankstipranks
Ironwood Pharma (IRWD)
NASDAQ:IRWD
US Market

Ironwood Pharma (IRWD) Financial Statements

Compare
280 Followers

Ironwood Pharma Financial Overview

Ironwood Pharma's market cap is currently $304.05M. The company's EPS TTM is $-0.016; its P/E ratio is ―; Ironwood Pharma is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 442.74M$ 410.60M$ 413.75M$ 389.52M$ 428.41M
Gross Profit$ 337.95M$ 409.18M$ 412.23M$ 386.39M$ 404.54M
Operating Income$ -945.43M$ 250.34M$ 232.26M$ 142.94M$ 120.12M
EBITDA$ -924.86M$ 261.44M$ 233.33M$ 141.90M$ 101.13M
Net Income$ -1.00B$ 175.06M$ 528.45M$ 106.18M$ -15.31M
Balance Sheet
Cash & Short-Term Investments$ 92.15M$ 656.20M$ 620.13M$ 362.56M$ 177.02M
Total Assets$ 471.07M$ 1.10B$ 1.13B$ 559.24M$ 402.75M
Total Debt$ 715.54M$ 415.92M$ 475.80M$ 453.70M$ 431.22M
Net Debt$ 623.38M$ -240.29M$ -144.33M$ 91.14M$ 254.20M
Total Liabilities$ 817.37M$ 448.14M$ 521.02M$ 496.60M$ 496.00M
Stockholders' Equity$ -346.30M$ 652.38M$ 605.91M$ 62.64M$ -93.25M
Cash Flow
Free Cash Flow$ 183.15M$ 273.63M$ 261.63M$ 166.99M$ 3.54M
Operating Cash Flow$ 183.43M$ 273.76M$ 261.89M$ 168.84M$ 10.72M
Investing Cash Flow$ -1.03B$ -136.00K$ -265.00K$ -1.84M$ -11.14M
Financing Cash Flow$ 277.16M$ -237.55M$ -4.55M$ 18.55M$ -1.19M
Currency in USD

Ironwood Pharma Earnings and Revenue History

Ironwood Pharma Debt to Assets

Ironwood Pharma Cash Flow

Ironwood Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis